ALXN

Alexion Pharmaceuticals Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ALXN price

Alexion Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment ALXN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ALXN

Valuation

P/E

0.00

Sector 0.84

Industry 3.17

P/BV

0.00

Sector 1.82

Industry 2.07

P/Revenue (PSR)

Sector 1.48

Industry 1.64

EV/EBITDA

-1.48

Sector -43.66

Industry 1.20

EV/EBIT

-1.65

Sector -47.57

Industry -4.84

P/EBITDA

Sector -31.25

Industry -54.01

P/EBIT

Sector -42.58

Industry -51.46

P/Total Assets

Sector 0.82

Industry 0.91

P/Net Current Assets

0.00

Sector -23.77

Industry -9.63

P/Working Capital

0.00

Sector -3.73

Industry 2.63

EPS

3.10

Sector -0.70

Industry -0.60

BVPS

56.50

Sector 4.50

Industry 4.74

Efficiency

Gross Margin

90.94%

Sector 49.32%

Industry 50.68%

EBITDA Margin

43.10%

Sector -305.63%

Industry -57.47%

EBIT Margin

47.07%

Sector -19.73%

Industry -25.80%

Net Profit Margins

10.89%

Sector -23.90%

Industry -29.17%

Asset Turnover

0.09

Sector 0.13

Industry 0.15

Profitability

ROE

5.48%

Sector -24.30%

Industry -22.30%

ROA

3.66%

Sector -24.50%

Industry -24.15%

ROIC

19.10%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.52

Sector 1.92

Industry 1.98

Net Debt / EBITDA

-1.48

Sector -23.10

Industry -2.21

Net Debt / EBIT

-1.65

Sector -17.84

Industry -1.50

Net Debt / Equity

-0.08

Sector -0.68

Industry -0.29

Gross Debt / Equity

0.19

Sector -0.72

Industry -0.82

Equity/Assets

0.67

Sector 0.46

Industry 0.47

Liabilities/Assets

0.33

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

30.78%

Sector -

Industry -

5Y Earnings CAGR

1.40%

Sector -

Industry -

Fundamentals ALXN

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Alexion Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$62.78

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ALXN Alexion Pharmaceuticals Inc.	$0.00	-	0.00%	0.00	0.00	5.48%	10.89%
NVS Novartis AG	$153.71	18.90%	2.05%	22.56	6.86	30.41%	23.29%
JNJ Johnson & Johnson	$256.00	35.86%	2.08%	29.04	7.19	24.76%	21.48%
LLY Eli Lilly and Compay	$1,270.45	58.04%	0.53%	42.13	33.21	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$431.94	-5.79%	0.00%	49.29	8.45	17.15%	28.44%
SNY Sanofi	$41.28	-13.73%	4.38%	3.78	0.70	18.43%	14.25%
TMO Thermo Fisher Scientific Inc.	$702.29	29.58%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$98.90	-20.18%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$93.53	0.73%	3.02%	23.20	2.39	10.29%	13.93%
GSK GlaxoSmithKline PLC	$50.10	17.47%	3.58%	15.38	4.34	28.24%	14.54%
CVS CVS Health Corporation	$94.53	19.14%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.55	-55.68%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$73.66	-38.57%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$555.11	-13.72%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$246.53	-8.21%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$231.51	5.83%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$462.26	7.23%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$236.56	96.81%	0.00%	57.23	4.10	7.16%	11.31%
SYK Stryker Corp.	$297.11	-21.02%	1.18%	30.25	4.70	15.55%	14.43%
PHG Koninklijke Philips NV	$26.28	-4.06%	3.91%	19.13	1.87	9.80%	6.30%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALXN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

34 years

Founded: 1992

1996

Time since IPO - 30 years

3.837

Employees

Alexion Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $12.43 billion.

The company employs approximately 3.837 people and operates in the Health sector, within the Main Medications industry.

Over the past 12 months, Alexion Pharmaceuticals Inc. reported $6.26 billion in revenue, generating net income of $681.80 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALXN.

Market cap

Net worth

$12.43 billion

$12,431,000,000.00

Assets

$18.65 billion

$18,650,200,000.00

Total Shares Outstanding

220.00 million

220,000,000

Average Daily Trading Volume

$5.81 million

$5,809,888.66

Sector

Health

Industry

Main Medications

ALXN

ALXN revenue and profits

Financial Results ALXN

DRAG THE FRAME TO SEE MORE DATA

ALXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.53 18,33% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$306.27 1,85% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$70.46 95,17% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$426.68 46,93% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$41.28 --13,61% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$256.00 37,16% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,270.45 59,90% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$462.26 7,51% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76